Defense contractor Lockheed Martin (NYSE:LMT) received a renewal of its lucrative NASA "Human Health and Performance Contract" Monday, announcing that NASA's Johnson Space Center will continue to retain its services in providing "biomedical, medical and health services in support of all human spaceflight programs."
Lockheed puts the estimated value of the 10-year contract at a combined $250 million. The company will be responsible for everything from developing flight hardware to facilitating life sciences research conducted aboard the International Space Station, optimizing tools and experiments for astronauts working in zero gravity, analyzing radiation, developing "space food," training flight and ground crews, and archiving life sciences data.
Contract win nothwithstanding, Lockheed shares declined 0.4% in Monday trading to close at $92.36.
Fool contributor Rich Smith has no position in any stocks mentioned. The Motley Fool owns shares of Lockheed Martin. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.